Review Article| Volume 22, ISSUE 9, P1889-1897.e5, September 2021

Potential Overtreatment and Undertreatment of Type 2 Diabetes Mellitus in Long-Term Care Facilities: A Systematic Review



      To investigate the prevalence, outcomes, and factors associated with potential glycemic overtreatment and undertreatment of type 2 diabetes mellitus (T2DM) in long-term care facilities (LTCFs).


      Systematic review.

      Setting and Participants

      Residents with T2DM and aged ≥60 years living in LTCFs.


      Articles published between January 2000 and September 2020 were retrieved following a systematic search of MEDLINE, EMBASE, Cochrane Library, CINAHL plus, and gray literature. Inclusion criteria were the reporting of (1) potential overtreatment and undertreatment quantitatively defined (implicitly or explicitly) based on hemoglobin A1c (HbA1c) and/or blood glucose; (2) prevalence, outcomes, and associated factors of potential glycemic overtreatment and undertreatment; and (3) the study involved residents of LTCFs.


      Fifteen studies were included. Prevalence of potential overtreatment (5%–86%, n = 15 studies) and undertreatment (1.4%–35%, n = 8 studies) varied widely among facilities and geographical locations, and according to definitions used. Prevalence of potential overtreatment was 16%–74% when defined as treatment with a glucose-lowering medication in a resident with ≥1 hypoglycemia risk factor or serious comorbidity, together with a HbA1c <7% (n = 10 studies). Potential undertreatment was commonly defined as residents on glucose-lowering medication having HbA1c >8.5% and the prevalence 1.4%–14.8% (n = 6 studies). No studies prospectively measured resident health outcomes from overtreatment and undertreatment. Potential overtreatment was positively associated with use of oral glucose-lowering medications, dementia diagnosis or dementia severity, and/or need for assistance with activities of daily living (n = 2 studies). Negative association was found between potential overtreatment and use of insulin/combined insulin and oral glucose-lowering medication. No studies reported factors associated with potential undertreatment.

      Conclusions and Implications

      The prevalence of potential glycemic overtreatment and undertreatment varied widely among residents with T2DM depending on the definition(s) used in each study. Longitudinal studies examining associations between glycemic management and health outcomes, and the use of consensus definitions of overtreatment and undertreatment are required to establish findings about actual glycemic overtreatment and undertreatment in LTCFs.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the American Medical Directors Association
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Ogurtsova K.
        • da Rocha Fernandes J.
        • Huang Y.
        • et al.
        IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040.
        Diabetes Res Clin Pract. 2017; 128: 40-50
        • Bauduceau B.
        • Le Floch J.-P.
        • Halimi S.
        • et al.
        Cardiovascular complications over 5 years and their association with survival in the GERODIAB cohort of elderly French patients with type 2 diabetes.
        Diabetes Care. 2018; 41: 156-162
        • Sinclair A.
        • Dunning T.
        • Rodriguez-Manas L.
        Diabetes in older people: New insights and remaining challenges.
        Lancet Diabetes Endocrinol. 2015; 3: 275-285
        • Andreassen L.M.
        • Kjome R.L.
        • Solvik U.O.
        • et al.
        The potential for deprescribing in care home residents with Type 2 diabetes.
        Int J Clin Pharm. 2016; 38: 977-984
        • Szczerbińska K.
        • Topinková E.
        • Brzyski P.
        • et al.
        The characteristics of diabetic residents in European nursing homes: Results from the SHELTER study.
        J Am Med Dir Assoc. 2015; 16: 334-340
        • Hjaltadóttir I.
        Sigurðardóttir Á. Prevalence of diabetes as well as general health status of Icelandic nursing home residents 2003–2012.
        Laeknabladid. 2015; 101: 79-84
        • Duffy R.E.
        • Mattson B.J.
        • Zack M.
        Comorbidities among Ohio’s nursing home residents with diabetes.
        J Am Med Dir Assoc. 2005; 6: 383-389
        • Travis S.S.
        • Buchanan R.J.
        • Wang S.
        • Kim M.
        Analyses of nursing home residents with diabetes at admission.
        J Am Med Dir Assoc. 2004; 5: 320-327
        • Biessels G.J.
        • Staekenborg S.
        • Brunner E.
        • et al.
        Risk of dementia in diabetes mellitus: A systematic review.
        Lancet Neurol. 2006; 5: 64-74
        • Simó R.
        • Ciudin A.
        • Simó-Servat O.
        • Hernández C.
        Cognitive impairment and dementia: A new emerging complication of type 2 diabetes—the diabetologist’s perspective.
        Acta Diabetol. 2017; 54: 417-424
        • Abdelhafiz A.H.
        • McNicholas E.
        • Sinclair A.J.
        Hypoglycemia, frailty and dementia in older people with diabetes: Reciprocal relations and clinical implications.
        J Diabetes Complications. 2016; 30: 1548-1554
        • Caughey G.E.
        • Roughead E.E.
        • Vitry A.I.
        • et al.
        Comorbidity in the elderly with diabetes: Identification of areas of potential treatment conflicts.
        Diabetes Res Clin Pract. 2010; 87: 385-393
        • Abdelhafiz A.H.
        • Sinclair A.J.
        Deintensification of hypoglycaemic medications—use of a systematic review approach to highlight safety concerns in older people with type 2 diabetes.
        Diabetes Res Clin Pract. 2018; 32: 444-450
        • Tsuji I.
        • Whalen S.
        • Finucane T.E.
        Predictors of nursing home placement in community-based long-term care.
        J Am Geriatr Soc. 1995; 43: 761-766
        • Russell L.B.
        • Valiyeva E.
        • Roman S.H.
        • et al.
        Hospitalizations, nursing home admissions, and deaths attributable to diabetes.
        Diabetes Care. 2005; 28: 1611-1617
        • Kirkman M.S.
        • Briscoe V.J.
        • Clark N.
        • et al.
        Diabetes in older adults.
        Diabetes Care. 2012; 35: 2650-2664
        • Kalyani R.R.
        • Tian J.
        • Xue Q.L.
        • et al.
        Hyperglycemia and incidence of frailty and lower extremity mobility limitations in older women.
        J Am Geriatr Soc. 2012; 60: 1701-1707
        • Lipska K.J.
        • Ross J.S.
        • Wang Y.
        • et al.
        National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011.
        JAMA Intern Med. 2014; 174: 1116-1124
        • Lipska K.J.
        • Warton E.M.
        • Huang E.S.
        • et al.
        HbA1c and risk of severe hypoglycemia in type 2 diabetes: The Diabetes and Aging Study.
        Diabetes Care. 2013; 36: 3535-3542
        • Shehab N.
        • Lovegrove M.C.
        • Geller A.I.
        • et al.
        US emergency department visits for outpatient adverse drug events, 2013–2014.
        JAMA. 2016; 316: 2115-2125
        • Geller A.I.
        • Shehab N.
        • Lovegrove M.C.
        • et al.
        National estimates of insulin-related hypoglycemia and errors leading to emergency department visits and hospitalizations.
        JAMA Intern Med. 2014; 174: 678-686
        • Rodríguez-Sánchez B.
        • Angelini V.
        • Feenstra T.
        • Alessie R.J.M.
        Diabetes-associated factors as predictors of nursing home admission and costs in the elderly across Europe.
        J Am Med Dir Assoc. 2017; 18: 74-82
        • Dunning T.A.
        • Savage S.
        • Duggan N.
        The McKellar Guidelines: Helping plan care for older people with diabetes.
        Aust Nurs Midwifery J. 2016; 23: 49
        • Munshi M.N.
        • Florez H.
        • Huang E.S.
        • et al.
        Management of diabetes in long-term care and skilled nursing facilities: A Position Statement of the American Diabetes Association.
        Diabetes Care. 2016; 39: 308-318
        • Sinclair A.J.
        • Abdelhafiz A.
        • Dunning T.
        • et al.
        An international position statement on the management of frailty in diabetes mellitus: Summary of recommendations 2017.
        J Frailty Aging. 2018; 7: 10-20
        • Stasinopoulos J.
        • Bell J.S.
        • Manski-Nankervis J.
        • et al.
        Medication management of type 2 diabetes in residential aged care.
        Aust J Gen Pract. 2018; 47: 675-681
        • de Souto Barreto P.
        • Sanz C.
        • Vellas B.
        • et al.
        Drug treatment for diabetes in nursing home residents.
        Diabet Med. 2014; 31: 570-576
        • de Souto Barreto P.
        • Lapeyre-Mestre M.
        • Vellas B.
        • Rolland Y.
        Multimorbidity type, hospitalizations and emergency department visits among nursing home residents: A preliminary study.
        J Nutr Health Aging. 2014; 18: 705-709
        • Moher D.
        • Liberati A.
        • Tetzlaff J.
        • et al.
        Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement.
        PLoS Med. 2009; 6: e1000097
      1. Potential over-treatment and under-treatment of type 2 diabetes mellitus in residential aged care: A systematic review. [Internet]. PROSPERO International prospective register of systematic reviews.
        (Available at:)
        • Dhaliwal R.
        • Weinstock R.S.
        Management of type 1 diabetes in older adults.
        Diabetes Spectrum. 2014; 27: 9-20
        • Aromataris E.
        • Munn Z.
        JBI Manual for Evidence Synthesis. JBI.
        2017 (Available at:)
        Date accessed: May 19, 2021
        • Munn Z.
        • Moola S.
        • Lisy K.
        • et al.
        Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and incidence data.
        Int J Evid Based Healthc. 2015; 13: 147-153
        • Moola S.
        • Munn Z.
        • Tufanaru C.
        • et al.
        Chapter 7: Systematic reviews of etiology and risk.
        in: Aromataris E. Munn Z. Joanna Briggs Institute Reviewer’s Manual. The Joanna Briggs Institute, Adelaide, SA, Australia2017
        • Niznik J.D.
        • Hunnicutt J.N.
        • Zhao X.
        • et al.
        Deintensification of diabetes medications among veterans at the end of life in VA nursing homes.
        J Am Geriatr Soc. 2020; 68: 736-745
        • Lederle L.
        • Jing B.
        • Rodriguez A.
        • et al.
        Glycemic over- and undertreatment in VA nursing home residents with type 2 diabetes: A retrospective cohort study.
        J Gen Intern Med. 2020; 35: 1900-1902
        • Newton C.A.
        • Adeel S.
        • Sadeghi-Yarandi S.
        • et al.
        Prevalence, quality of care, and complications in long term care residents with diabetes: A multicenter observational study.
        J Am Med Dir Assoc. 2013; 14: 842-846
        • Abbatecola A.M.
        • Bo M.
        • Armellini F.
        • et al.
        Tighter glycemic control is associated with ADL physical dependency losses in older patients using sulfonylureas or mitiglinides: Results from the DIMORA study.
        Metabolism. 2015; 64: 1500-1506
        • Bo M.
        • Gallo S.
        • Zanocchi M.
        • et al.
        Prevalence, clinical correlates, and use of glucose-lowering drugs among older patients with type 2 diabetes living in long-term care facilities.
        J Diabetes Res. 2015; 2015: 174316
        • Basso A.
        • Peruzzi P.
        • Carollo M.C.
        • et al.
        Assessment of glycemic control among diabetic residents in nursing homes.
        Diabetes Res Clin Pract. 2012; 96: e80-e83
        • Quilot E.
        • Petit J.-M.
        • Vergès B.
        • Bouillet B.
        Are older patients with diabetes still being overtreated in French long-term care homes?.
        Age Ageing. 2020; 49: 878-882
        • Retornaz F.
        • Grino M.
        • Mari L.
        • Oliver C.
        Assessment of glycemic control in nursing home residents with diabetes.
        J Nutr Health Aging. 2017; 21: 457-463
        • Bouillet B.
        • Valliant G.
        • Petit J.M.
        • et al.
        Are elderly patients with diabetes being overtreated in French long-term-care homes?.
        Diabetes Metab J. 2010; 36: 272-277
        • Andreassen L.M.
        • Sandberg S.
        • Kristensen G.B.
        • et al.
        Nursing home patients with diabetes: Prevalence, drug treatment and glycemic control.
        Diabetes Res Clin Pract. 2014; 105: 102-109
        • Walfridsson A.
        • Sehlberg M.
        • Gillespie U.
        • et al.
        Diabetes treatment and hypoglycaemic episodes in elderly patients at nursing homes in Uppsala County.
        Ups J Med Sci. 2016; 121: 179-183
        • Haines H.M.
        • Bannon-Murphy H.
        • Amos T.
        • Krones R.
        Prevalence and management of diabetes in residential aged care facilities in north-east Victoria, Australia.
        Aust Fam Physician. 2016; 45: 908-911
        • McCracken R.
        • McCormack J.
        • McGregor M.J.
        • et al.
        Associations between polypharmacy and treatment intensity for hypertension and diabetes: A cross-sectional study of nursing home patients in British Columbia,.
        Canada. BMJ Open. 2017; 7: e017430
        • Hatano Y.
        • Araki A.
        • Matsumoto M.
        • Ishibashi S.
        Low hemoglobin A1c and low body mass index are associated with dementia and activities of daily living disability among Japanese nursing home residents with diabetes.
        Geriatr Gerontol Int. 2019; 19: 854-860
        • Chandrakumar A.
        • Vikas P.V.
        • Tharakan P.G.
        • Aravind C.
        Prevalence of hypoglycemia among diabetic old age home residents in South India.
        Diabetes Metab Syndr. 2016; 10: S144-S146
        • Hambling C.E.
        • Seidu S.I.
        • Davies M.J.
        • Khunti K.
        Older people with Type 2 diabetes, including those with chronic kidney disease or dementia, are commonly overtreated with sulfonylurea or insulin therapies.
        Diabet Med. 2017; 34: 1219-1227
        • Thorpe C.T.
        • Gellad W.F.
        • Good C.B.
        • et al.
        Tight glycemic control and use of hypoglycemic medications in older veterans with type 2 diabetes and comorbid dementia.
        Diabetes Care. 2015; 38: 588-595
        • Huang E.S.
        Potential overtreatment of older, complex adults with diabetes.
        JAMA. 2015; 314: 1280-1281
        • Khunti K.
        • Davies M.J.
        Clinical inertia versus overtreatment in glycaemic management.
        Lancet Diabetes Endocrinol. 2018; 6: 266-268
        • Pogach L.
        • Tseng C.-L.
        • Soroka O.
        • et al.
        A proposal for an out-of-range glycemic population health safety measure for older adults with diabetes.
        Diabetes Care. 2017; 40: 518-525
        • Maciejewski M.L.
        • Mi X.J.
        • Sussman J.
        • et al.
        Overtreatment and deintensification of diabetic therapy among Medicare beneficiaries.
        J Gen Intern Med. 2018; 33: 34-41
        • Hart H.E.
        • Rutten G.E.
        • Bontje K.N.
        • Vos R.C.
        Overtreatment of older patients with type 2 diabetes mellitus in primary care.
        Diabetes Obes Metab. 2018; 20: 1066-1069
        • Tseng C.L.
        • Soroka O.
        • Maney M.
        • et al.
        Assessing potential glycemic overtreatment in persons at hypoglycemic risk.
        JAMA Intern Med. 2014; 174: 259-268
        • Pandya N.
        • Wei W.
        • Meyers J.L.
        • et al.
        Burden of sliding scale insulin use in elderly long-term care residents with type 2 diabetes mellitus.
        J Am Geriatr Soc. 2013; 61: 2103-2110
        • Sluggett J.K.
        • Ilomaki J.
        • Seaman K.L.
        • et al.
        Medication management policy, practice and research in Australian residential aged care: Current and future directions.
        Pharmacol Res. 2017; 116: 20-28
        • Lipska K.J.
        • Krumholz H.
        • Soones T.
        • Lee S.J.
        Polypharmacy in the aging patient: A review of glycemic control in older adults with type 2 diabetes.
        JAMA. 2016; 315: 1034-1045
        • Turner R.C.
        • Holman R.R.
        • Stratton I.M.
        • et al.
        Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34).
        Lancet. 1998; 352: 854-865
        • Gerstein H.C.
        • Miller M.E.
        • Byington R.P.
        • et al.
        Effects of intensive glucose lowering in type 2 diabetes.
        N Engl J Med. 2008; 358: 2545-2559
        • Miller M.
        • Bonds D.
        • Gerstein H.
        • et al.
        ACCORD investigators. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: Post hoc epidemiological analysis of the ACCORD study.
        BMJ. 2010; 340: b5444
        • Patel A.
        • MacMahon S.
        • Chalmers J.
        • et al.
        Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
        N Engl J Med. 2008; 358: 2560-2572
        • Duckworth W.
        • Abraira C.
        • Moritz T.
        • et al.
        Glucose control and vascular complications in veterans with type 2 diabetes.
        N Engl J Med. 2009; 360: 129-139
        • Huang E.S.
        • Liu J.Y.
        • Moffet H.H.
        • et al.
        Glycemic control, complications, and death in older diabetic patients: The diabetes and aging study.
        Diabetes Care. 2011; 34: 1329-1336
        • Hsu A.
        • Gan S.
        • Cenzer-Stijacic I.
        • Lee S.J.
        Glycemic control and functional decline in nursing home residents with diabetes.
        JAMA Intern Med. 2017; 177: 130-132
        • Sinclair A.
        • Walton C.
        ngland-wide care home diabetes audit 2012/13. Institute of Diabetes for Older People (IDOP), United Kingdom2014
        • Greenfield S.
        • Billimek J.
        • Pellegrini F.
        • et al.
        Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: A cohort study.
        Ann Intern Med. 2009; 151: 854-860
        • Alam T.
        • Weintraub N.
        • Weinreb J.
        What is the proper use of hemoglobin A1c monitoring in the elderly?.
        J Am Med Dir Assoc. 2006; 7: S60-S64
        • Deed G.
        • Ackermann E.
        • Arthur I.
        • et al.
        General Practice Management of type 2.
        in: Diabetes. Royal Australian College of General Practitioners (RACGP); East, Melbourne, Victoria2016–18, 2016: 50-51
        • Tahara Y.
        • Shima K.
        Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level.
        Diabetes Care. 1995; 18: 440-447
        • Heald A.H.
        • Anderson S.G.
        • Cortes G.J.
        • et al.
        Hypoglycaemia in the over 75s: Understanding the predisposing factors in type 2 diabetes (T2DM).
        Prim Care Diabetes. 2018; 12: 133-138
        • Davis K.L.
        • Wei W.
        • Meyers J.L.
        • et al.
        Association between different hemoglobin A1c levels and clinical outcomes among elderly nursing home residents with type 2 diabetes mellitus.
        J Am Med Dir Assoc. 2014; 15: 757-762
        • Mattishent K.
        • Loke Y.K.
        Is avoidance of hypoglycaemia a better target than HbA1C in older people with diabetes?.
        Br J Clin Pharmacol. 2021; 87: 9-11